Eli Lilly said Thursday it will hike the UK list price of its diabetes and weight-loss drug Mounjaro by up to 170%.

Late last month, President Donald Trump issued letters to Lilly CEO David Ricks and to the CEOs of roughly a dozen other large pharmaceutical companies, giving them until late September to cut the U.S. prices of certain drugs or the administration will “deploy every tool in our arsenal to protect American families.”

Trump administration demands lower prices in the U.S., forcing the pharmaceutical company to raise them in other markets